Brightmeds NAD+ Review: $105/mo Means 12 Months Upfront

1. The pricing structure, and what the asterisk carries

The page title itself reads NAD+ Injections from $105/mo, and the hero says From $105 first month | then $155/mo, with an asterisk. The asterisk resolves to: Price shown applies to 12-Month Plan when paid upfront. Actual price will depend on the product and plan, if prescribed. Across the rest of the page we counted figures of $124, $148, $175, $196, $199 and $246, which is the shape you would expect from a ladder of shorter plans priced progressively higher per month.

So the advertised number is the best case on the longest lock-in, which is ordinary subscription pricing and would be unremarkable for a gym. It is not unremarkable here. A twelve-month upfront payment is roughly $1,260 for a compounded preparation of a substance with no randomised human trials supporting the outcomes being advertised. The whole reason to buy month by month is that you might discover it does nothing for you, and the annual plan is precisely the instrument that removes that option.

Two smaller notes on cost. There is a $50 first-order discount applied automatically at checkout, which is real money on a first month. And the product is described as FSA and HSA eligible, which for many US buyers is effectively a discount in pre-tax dollars — worth knowing, though eligibility ultimately depends on your plan administrator rather than on a vendor's badge.

2. Where this company is genuinely better than its competitors

We should be specific about the credit, because it is unusual. First, the compounding paragraph quoted above appears on the marketing landing page. It says compounded medicines are not FDA-approved, explains why in terms of the patient-specific prescription, and warns that risk and efficacy profiles are hard to compare with approved products. Most companies in this category either omit that or bury it in terms of service. One we reviewed put a dietary-supplement disclaimer on a prescription drug instead, which is worse than saying nothing.

Second, the Zepbound arrangement. Brightmeds lists FDA-approved Zepbound pens and vials at a $100 Brightmeds doctor consult fee, with the prescription sent to LillyDirect or your preferred local pharmacy and the medication cost billed separately by whoever fulfils it. That structure does two honest things: it prices the clinical service transparently and separately, and it declines to insert a margin between the patient and the manufacturer's own distribution channel. It also means the company is offering the approved product as a real option rather than steering everyone to the compounded version it earns more on.

Third, some smaller things that indicate a functioning operation. A 100% money back guarantee if your prescription is not approved, which removes the risk of paying for a consultation that goes nowhere. A statement that brightmeds.com does not itself provide medical or pharmacy services but partners with medical professionals on HIPAA-compliant platforms — an accurate description of how these businesses actually work. A published Important Safety Information page. Instruction pages for each injectable, including NAD+, glutathione, sermorelin and TRT. And a Trustpilot link on the products page, which is a company inviting a comparison rather than avoiding one.

3. The cross-sell, which is the real subject of this review

Look at the product menu as a patient would. Compounded tirzepatide and semaglutide, plus microdosing versions of each. FDA-approved Zepbound in pens and vials. Testosterone replacement. Sermorelin. Glutathione. NAD+. One of those categories rests on some of the largest and most consistent weight-management trials ever run. The rest do not, and they are presented in the same grid with the same styling and the same Get Started button.

The claims attached to the longevity products are the ordinary overreach of the category. NAD+: promotes anti-aging and vitality, enhances mental clarity and vitality, helps increase the energy production of our body's cells and can protect DNA from age-related damage, a prescription can help you maintain a more youthful you, and the heading Wellness backed by science. Glutathione: makes your skin glow, strengthens the immune system, supports liver health. Sermorelin: supports lean muscle growth, promotes recovery and energy, improves fat metabolism. To their credit the page does hedge in places — may help improve mental clarity and focus, helps support energy at the cellular level — but protecting DNA from age-related damage is not a hedge, and it is not established.

The specific risk is not that someone stumbles onto an NAD+ page and buys it. It is sequencing. A person starts compounded tirzepatide, loses weight, feels the service has delivered, and is then presented with three more injectables by the provider that earned that trust. They already inject weekly, so an additional injection is no longer a psychological barrier. They already accept compounded medicine, because the drug that worked was compounded. The reasoning that got them the first result does not transfer to the other three, but the confidence does. If you take a GLP-1 from Brightmeds, treat the longevity menu as advertising from a company you happen to buy medicine from, and put any of it to your own clinician before adding it.

4. Eligibility, states and the BMI rule

The state exclusions are extensive and product-specific, and they are the first thing to check because everything else is wasted effort if you live in the wrong place. Subcutaneous products — which includes NAD+ — are excluded in twelve states: Alabama, Alaska, Delaware, Hawaii, Louisiana, Massachusetts, Missouri, Mississippi, Rhode Island, South Carolina, Wisconsin and Wyoming. The GLP-1s along with sildenafil and tadalafil are excluded in five: Alabama, Arkansas, Louisiana, Mississippi and South Carolina. Those lists overlap but are not the same, so confirm the product you want against the state you are in.

On the weight-loss side, the affiliate material states that doctors can only prescribe if BMI is over 30. That is worth understanding because it is stricter than the approved labelling for these medicines, which covers a BMI of 30 or above, or 27 or above where there is a weight-related health condition such as hypertension, dyslipidaemia or obstructive sleep apnoea. A blanket BMI-over-30 rule therefore excludes people who would qualify clinically. Being more conservative than the label is a defensible choice for a remote service and we are not criticising it — but if you are between 27 and 30 with a related condition, know that this particular door is closed before you spend time at it.

One further note on the GLP-1 offering, since it is what most readers here will care about. Brightmeds sells compounded semaglutide and tirzepatide alongside the approved Zepbound. Compounded copies of drugs that are commercially available sit in contested regulatory territory, and the sensible question to ask any provider offering both is why you would take the unapproved version when the approved one is available through the channel they will happily refer you to for $100. If the answer is price, that is a real answer — but it should be given as a price decision, not framed as a clinical equivalence.

What is Brightmeds and what does it sell?

A US telehealth platform selling a wide range of prescription products: compounded semaglutide and tirzepatide including microdosing versions, FDA-approved Zepbound pens and vials, testosterone replacement, sermorelin, glutathione injections and NAD+ injections. This review concerns the NAD+ offer that came through our affiliate queue, but the range matters more than the product — because the same service prescribing your weight-loss medication is also selling you three injectables with no meaningful efficacy evidence behind them.

What does the NAD+ actually cost?

The headline is from $105 a month. The asterisk, which we found on the same page, reads: price shown applies to 12-Month Plan when paid upfront. So $105 is the rate you get for handing over roughly $1,260 in advance. The page separately shows from $105 first month, then $155 a month, and other figures across the page run to $124, $148, $175, $196, $199 and $246 — consistent with shorter commitments costing considerably more per month. There is a $50 first-order discount and the product is described as FSA and HSA eligible.

Should I pay for a year upfront?

No. Whatever you think of NAD+, prepaying twelve months for a compounded drug with no efficacy trials behind it is the wrong shape of commitment. You would be betting a four-figure sum on a product you cannot yet know works for you, from a category where nobody has demonstrated it works for anyone. If you want to try it, pay monthly, accept the higher rate as the price of not being locked in, and decide after eight weeks whether you can tell any difference at all.

Is it FDA-approved?

No, and Brightmeds says so more clearly than most. Their landing page states that compounded pharmaceuticals are made to a prescription for a specific patient and are therefore not FDA-approved, and adds that it may be challenging to directly compare the results and risk profiles of FDA-approved and compounded medicines because of differences in strength, dose and other factors. That is an accurate and unusually candid paragraph, printed on a sales page rather than buried in terms. NAD+ is not an approved drug for any indication in the United States.

What is the best thing about this company?

The Zepbound route, which is genuinely well handled. For the FDA-approved product Brightmeds charges a flat $100 doctor consult fee and then sends the prescription to LillyDirect or your own pharmacy, with the medication billed separately by whoever dispenses it. In other words they charge for the clinical work and do not mark up the drug. That separates the two things a patient should be able to see separately, and it points people towards the manufacturer's own channel. Very few telehealth companies in this space do that.

So what is the concern?

The cross-sell. A platform that legitimately prescribes GLP-1 medication — including routing you to the approved product at cost — also offers NAD+ injections, glutathione injections and sermorelin to the same patients, with claims like promotes anti-aging and vitality, makes your skin glow, and improves fat metabolism. None of those three has the evidence base the GLP-1 does. The credibility earned by handling Zepbound properly ends up lending cover to products that have not earned it, and the person most exposed to that is someone who already trusts the service because their weight-loss treatment is working.

Where is it not available?

This offer excludes a substantial list of states, which is worth checking before you spend time on a consultation. For subcutaneous products the excluded states are Alabama, Alaska, Delaware, Hawaii, Louisiana, Massachusetts, Mississippi, Missouri, Rhode Island, South Carolina, Wisconsin and Wyoming. For semaglutide, tirzepatide, sildenafil and tadalafil the excluded list is Alabama, Arkansas, Louisiana, Mississippi and South Carolina. Different products, different maps — confirm your own state covers the specific product you want.

What are the eligibility rules?

For the weight-loss side, the affiliate material states that doctors can only prescribe if BMI is over 30. That is more restrictive than the approved labelling for these medicines, which also covers a BMI of 27 or above where a weight-related health condition is present — so people who would qualify clinically elsewhere may be turned away here. Being stricter than the label is not a criticism in itself; it is simply a blunt rule, and if you are in that 27-to-30 band with a related condition you should know before you start rather than after.

Have you reviewed injectable NAD+ before?

Yes, and we went through the evidence in detail in a separate review of another provider, where we read every citation on its landing page and found no randomised human trial of injected NAD+ among them. Rather than repeat that here, the short version: NAD+ is a genuine and essential coenzyme, the biology is real, human trials have mostly used oral precursors and have reliably raised blood levels without reliably improving how people feel, and cells do not readily take up intact NAD+ from outside. Nobody has shown that injecting it does what these pages say.